login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
UNITY BIOTECHNOLOGY INC (UBX) Stock News
USA
- NASDAQ:UBX -
US91381U2006
-
Common Stock
0.2001
USD
-0.1 (-33.41%)
Last: 7/8/2025, 8:00:01 PM
0.1754
USD
-0.02 (-12.34%)
After Hours:
7/8/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
UBX Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: Benzinga
- Mentions:
MBRX
ICU
BSGM
NDRA
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
6 months ago - By: Benzinga
- Mentions:
ME
TGL
ANAB
AZEK
...
Crude Oil Gains 1%; US Composite PMI Surges In March
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
5 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
6 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
6 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
6 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
6 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
7 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors
7 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors
7 months ago - By: Unity Biotechnology, Inc.
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Please enable JavaScript to continue using this application.